Conférence

Multisarc

Réalisation : 7 novembre 2014 Mise en ligne : 7 novembre 2014
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
  • audio 1 audio 2 audio 3
Descriptif

Translational science : how to move from biology to clinical applications

Soft-tissues sarcomasrepresent an heterogeneous group of tumors. Stadard of care is surgicalresection followed by radiotherapy. Patients with metastatic relapse aretreated with chemotherapy but the overall survival is only approximatly 18months.Actual research try to define new therapeutic targets, adapted to the type ofsarcoma.

The personalized medicineproject aims to propose to patients with advanced sarcoma a targeted therapybased on the genomic and immunilogical profile.The main difference with other projects resides in the genomic profile, whichwill be determined with a "whole genome" analysis.

Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation)
Conditions d'utilisation
Creative Commons (BY NC)
Citer cette ressource:
Univ Bordeaux. (2014, 7 novembre). Multisarc. [Vidéo]. Canal-U. https://www.canal-u.tv/75305. (Consultée le 27 janvier 2022)
Contacter

Dans la même collection

  • BRIO support to scientists
    Conférence
    00:13:28
    BRIO support to scientists
    Dessis
    Damien

    BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

  • Translational cancer genomics and proteomics
    Conférence
    00:29:16
    Translational cancer genomics and proteomics
    Sleijfer
    Stefan

    Translational science : how to move from biology to clinical applications Evaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as “liquid biopsy” to define and establish

  • Curing leukemia ?
    Conférence
    00:19:52
    Curing leukemia ?
    Mahon
    François-Xavier

    Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

  • Cost-effectiveness analysis for decision making, illustrated theory
    Conférence
    00:19:20
    Cost-effectiveness analysis for decision making, illustrated theory
    Bénard
    Antoine

    Interface technology/clinical/SHS/public health : case study interventional radiology In a health care system with limited resources, each euro invested in a health care intervention is no longer

  • Expert panel discussions : why translational research matters
    Conférence
    01:00:29
    Expert panel discussions : why translational research matters

    En point d'orgue du Scientific BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur  à l'Université d'Edimbourg, anime un débat sur la question de la recherche dite translationnelle,

Sur le même thème